Nimodipine is more effective than nifedipine in attenuating morphine tolerance on chronic co-administration in the rat tail-flick test

Indian Journal of Experimental Biology

Volumn 46, Issue 4, 2008, Pages 219-228

  Ray, Subrata Basu ^a   Mishra, Pravash ^a   Verma, Dilip ^a   Gupta, Ankur ^a   Wadhwa, Shashi ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Ca2+ channel blockers; Morphine tolerance; Neuronal plasticity; Nifedipine; Nimodipine

Indexed keywords

RATTUS; RATTUS NORVEGICUS;

CALCIUM CHANNEL BLOCKING AGENT; MORPHINE; NARCOTIC ANALGESIC AGENT; NIFEDIPINE; NIMODIPINE;

ANIMAL; ANIMAL BEHAVIOR; ARTICLE; COMPARATIVE STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG COMBINATION; DRUG EFFECT; DRUG TOLERANCE; EXERCISE; MALE; PAIN; PAIN ASSESSMENT; PAIN THRESHOLD; RAT; WISTAR RAT;

ANALGESICS, OPIOID; ANIMALS; BEHAVIOR, ANIMAL; CALCIUM CHANNEL BLOCKERS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; DRUG TOLERANCE; MALE; MORPHINE; NIFEDIPINE; NIMODIPINE; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; RATS; RATS, WISTAR; RESTRAINT, PHYSICAL;

EID: 45849136713     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Davis M P, Walsh D, Lagman R & LeGrand S B, Controversies in pharmacotherapy of pain management, Lancet Oncol, 6 (2005) 696.
2. Fallon M, The current situation with cancer pain, in: Pain 2005 - An updated review: Refresher Course Syllabus, edited by D M Justins (IASP Press, Seattle, USA) 2005, 165.
3. Bell RF, Low-dose subcutaneous ketamine infusion and morphine tolerance, Pain, 83 (1999) 101.
4. Law P Y, Wong Y H & Loh H H, Molecular mechanisms and regulation of opioid receptor signalling, Ann Rev Pharmacol Toxicol 40 (2000) 389.
5. Santillan R, Hurle M A, Armijo J A, Mozos R D L & Florez J, Nimodipine-enhanced opiate analgesia in cancer patients requiring morphine dose escalation: A double blind, placebocontrolled study, Pain, 76 (1998) 17.
6. Roca G, Aguilar J L, Gomar C, Mazo V, Costa J & Vidal F, Nimodipine fails to enhance the analgesic effect of slow release morphine in the early phases of cancer pain treatment, Pain, 68 (1996) 239.
7. Lee S C & Yoburn B C, The effect of nimodipine on opioid antagonist-induced upregulation and supersensitivity, Pharmacol Biochem Behav, 66 (2000) 347.
8. Carta F, Bianchi M, Argenton S, Cervi D, Marolla G, Tamburini M, Breda M, Fantoni A & Panerai A E, Effect of nifedipine on morphine-induced analgesia, Anesth Analg, 70 (1990) 493.
9. Dierssen M, Fló rez J & Hurlé M A, Calcium channel modulation by dihydropyridines modifies sufentanil-induced antinociception in acute and tolerant conditions, Naunyn Schmiedeberg's Arch Pharmacol, 342 (1990) 559.
10. Antkiewicz-Michaluk L, Michaluk J, Romanska I & Vetulani J, Reduction of morphine dependence and potentiation of analgesia by chronic co-administration of nifedipine, Psychopharmacol, 111 (1993).
11. 2+ channel antagonists on morphine analgesia, tolerance and dependence, and on blood pressure in the rat, Eur J Pharmacol, 352 (1998) 189.
12. Contreras E, Tamayo l & Amigo M, Calcium channel antagonists increase morphine-induced analgesia and antagonize morphine tolerance, Eur J Pharmacol, 148 (1988) 463.
13. Verma V, Mediratta P K & Sharma K K. Interaction of pentazocine with calcium channel blocking drugs during chemical and thermal pain in mice. Indian J Physiol Pharmacol, 44 (2000) 255.
14. Verma V, Mediratta P K & Sharma K K, Potentiation of analgesia and reversal of tolerance to morphine by calcium channel blockers, Indian J Exp Biol, 39 (2001) 636.
15. Dogrul A, Zagli U & Tulunay F C, The role of T-type calcium channels in morphine analgesia, development of antinociceptive tolerance and dependence to morphine, and morphine abstinence syndrome, Life Sci, 71 (2002) 725.
16. 2+ channel enhanced morphine analgesia and reduced morphine tolerance, Eur J Neurosci, 2004; 20 (2004) 3516.
17. v3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception. EMBO J, 24 (2005) 315.
18. Bars D L, Gozariu M & Cadden S W, Animal models of nociception, Pharmacol Rev, 53 (2001) 597.
19. D'Amour F E & Smith D L, A method for determining loss of pain sensation, J Pharmacol Exp Ther, 72 (1941) 74.
20. Shimizu N, Kishioka S, Maeda T, Fukazawa Y, Yamamoto C, Ozaki M & Yamamoto H, Role of pharmacokinetic effects in the potentiation of morphine analgesia by L-type calcium channel blockers in mice, J Pharmacol Sci, 94 (2004) 240.
21. Shimizu N, Kisioka S, Maeda T, Fukazawa Y, Dake Y, Yamamot C, Ozaki M & Yamamoto H. Involvement of peripheral mechanism in the verapamil-induced potentiation of morphine analgesia in mice, J Pharmacol Sci, 95 (2004) 452.
22. 2+ channels in neuroblastoma-glioma hybrid cells, Eur J Pharmacol, 342 (1998) 339.
23. Li S N, Brater M & Andreas K, Nimodipine and nitredipine inhibit N-type calcium channels in dibutyrl cAMPdifferentiated neuroblastoma x glioma hybrid (NG 108-15) cells, Neurosci Lett, 230 (1997) 85.
24. Scriabine A & Van den Kerckhoff W, Pharmacology of nimodipine. A review. Ann N Y Acad Sci USA., 522 (1988) 698.
25. Gintzler A R & Chakrabarti S, Post-opioid receptor adaptations to chronic morphine; altered functionality and associations of signalling molecules, Life Sciences, 79 (2006) 717.
26. Lacinova L, Voltage-dependent calcium channels, Gen Physiol Biophys, 24 (Suppl) (2005) 1.
27. Trimmer J S & Rhodes K J, Localization of voltage-gated ion channels in mammalian brain, Ann Rev Physiol, 66 (2004)477.
28. West A E, Chen W G, Dalva M B, Dolmetsch R E, Kornhauser J M, Shaywitz A J, Takasu M A, Tao X & Greenberg M E, Calcium regulation of neuronal gene expression, Proc Natl Acad Sci USA, 98 (2001) 11024.
29. West A E, Griffith E C & Greenberg M E, Regulation of transcription factors by neuronal activity, Nat Rev Neurosci, 3 (2002) 921.
30. Li X & Clark J D, Morphine tolerance and transcription factor expression in mouse spinal cord tissue, Neurosci Lett, 272 (1999) 79.
31. Fukuchi M, Tabuchi A & Tsuda M, Transcriptional regulation of neuronal genes and its effect on neural functions: Cumulative mRNA expression of PACAP and BDNFgenes controlled by calcium and cAMP signals in neurons, J Pharmacol Sci, 98 (2005) 212.